Filing Details
- Accession Number:
- 0001209191-17-056034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-04 19:31:49
- Reporting Period:
- 2017-10-02
- Accepted Time:
- 2017-10-04 19:31:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594864 | Juno Therapeutics Inc. | JUNO | Biological Products, (No Disgnostic Substances) (2836) | 463656275 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1616640 | Sunil Agarwal | C/O 400 Dexter Avenue North Suite 1200 Seattle WA 98109 | President Of R & D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-02 | 7,285 | $44.76 | 84,549 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were executed pursuant to a trading plan adopted by the reporting person on April 27, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- This transaction was executed in multiple trades at prices ranging from $44.50 to $45.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
